Abstract
Experimental work in vivo (McCarty, 1970) has shown that the introduction of monosodium urate crystals into a joint cavity initiates an acute inflammatory response. Polymorphonuclear leukocytes are normally present in synovial fluid and phagocytosis of crystals by polymorphonuclear leukocytes occurs readily. Experimental work on animals has shown that the phagocytosis of crystals by polymorphonuclear leukocytes occurs independently of complement (Spilberg and Osterland, 1970). The crystals are taken into phagosomes which then merge with primary lysosomes to form phagolysosomes or secondary lysosomes. Electron microscopic studies indicate that after a crystal lies in contact with the membrane of the phagolysosome, dissolution of the membrane occurs and is followed by cell death (Schumacher and Phelps, 1968). Cell death, however, appears to be a slow process, since neutrophils which have previously ingested urate crystals in vitro have been reported to exhibit a normal phagocytic capacity for yeast (Turner et al., 1973). Weissmann and Rita (1972) have postulated that lysis of the lysosomal membrane is due to the interaction of weakly anionic urate crystals with the membrane, forming cooperative hydrogen bonds with phosphate esters of membrane phospholipids. Not only do urate crystals disrupt lysosomal membranes, they also lyse red cells (Wallingford and McCarty, 1971), the plasma membrane of polymorphonuclear leukocytes (Spilberg et al., 1975), and liposomes (Weissman and Rita, 1972), lamellar arrays of phospholipids containing cholesterol in their membranes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Austic, R.E., Cole, R.K.: Impaired renal clearance of uric acid in chickens having hyperuricemia and articular gout. Amer. J. Physiol. 223, 525–530 (1972)
Bandmann, U., Rydgren, L., Norberg, B.: The difference between random movement and Chemotaxis. Effects of antitubulins on neutrophil granulocyte locomotion. Exp. Cell Res. 88, 63–73 (1974)
Becker, E.L., Sowell, H.J., Henson, P.M., Hsu, L.S.: The ability of chemotactic factors to induce lysosomal enzyme release. I. The characteristics of the release, the importance of surfaces and the relation of enzyme release to chemotactic responsiveness. J. Immunol. 112, 2045–2054 (1974)
Boucek, M.M., Snyderman, R.: Calcium influx requirement for human neutrophil Chemotaxis: inhibition by lanthanun chloride. Science 193, 905–907 (1976)
Bourne, H.R. et al.: Cyclic adnosine-3′, 5′-monophosphate and the regulation of human granulocyte function. J. clin. Invest. 49, 11 a Abstr. (1972)
Brai, M., Oster, A.G.: Studies on the C3 shunt activation in cobra venom induced lysis of unsen-sitized erythrocytes. Proc. Soc. exp. Biol. (Med.) 140, 1116–1121 (1972)
Bunch, T.W., Hunder, G.G., McDuffie, F.C., O’Brien, P.C., Markowitz, H.: Synovial fluid complement determination as a diagnostic aid in inflammatory joint diseases. Mayo Clin. Proc. 49, 715–720 (1974)
Canellakis, E.S., Tuttle, A.L., Cohen, P.P.: A comparative study of the end products of uric acid oxidation by peroxidases. J. biol. Chem. 213, 397–404 (1955)
Carter, S.B.: Principle of cell motility: the direction of cell movement and cancer invasion. Nature (Lond.) 108, 1183–1187 (1965)
Chang, Y.: Studies on phagocytosis. II. The effect of nonsteroidal anti-inflammatory drugs on phagocytosis and on urate crystal-induced canine joint inflammation. Pharm, exp. Ther. 183, 235–244 (1972)
Chang, Y., Gialla, E. J.: Suppression of urate crystalinduced canine joints inflammation by heterologous antipolymorphonuclear leukocyte serum. Arthr. and Rheum. 11, 145–150 (1968)
Cochrane, C. G., Revak, S. D., Aiken, B. S., Sitzer, S. S.: The structural characteristic and activation of Hageman factor in inflammation: mechanisms and control. In: Lepon, I.H., Ward, P.A. (Eds.). New York: Academic Press 1973
Cohn, A.Z., Morse, S.I.: Functional and metabolic properties of polymorphonuclear leukocytes. I. Observations in the requirements and consequences of particle ingestion. J. exp. Med. 111, 667–687 (1960)
Denko, C.W.: A phlogistic function of prostaglandin E1 in urate crystal inflammation. J. Rheum. 1, 222–229 (1974)
Dipasquale, G., Rassaert, R., Welaj, P., Tripp, L.: Influence of prostaglandins (PG)E2 and F2α on the inflammatory process. Prostaglandins 3, 741–757 (1973)
Donaldson, V.H., Gluek, H.I., Fleming, T.: Rheumatoid arthritis in a patient with Hageman trait. New Engl. J. Med. 286, 528–530 (1972)
Eisen, V.: Plasma kinins in synovial exudates. Brit. J. exp. Path. 51, 322–325 (1970)
Elsbach, P.: Composition and synthesis of lipids in resting and phagocyting leukocytes. J. exp. Med. 110, 969–980 (1959)
Fostiropoulus, K., Austen, K.F., Bloch, K.J.: Total hemolytic complement and second component of complement activity in serum and synovial fluid. Arthr. and Rheum. 8, 219–232 (1965)
Gallin, J.I., Durocher, J., Kaplan, A.P.: Interaction of leukocyte chemotactic factors with the cell surface. I. Chemotactic factor induced changes in human granulocyte surface charges. J. clin. Invest. 55, 967–974 (1975)
Glatt, M., Peska, B., Brune, K.: Leukocytes and prostaglandins in acute inflammation. Experien-tia (Basel) 30, 1257–1259 (1974)
Glatt, M., Peska, B., Brune, K.: Leukocytes and prostaglandins in acute inflammation. Experien-tia (Basel) 30, 1257–1259 (1974)
Goetzl, E.J., Austen, K.F.: A method for assessing the in vitro chemotactic response of neutrophil utilizing CR 51 labeled human leukocytes. Immunol. Commun. 1, 421–430 (1972)
Goetzl, E.J., Austen, K.F.: Active site chemotactic factors and the regulation of the human neutrophil chemotactic response. Antibiot. Chemother. 19, 218–232 (1974)
Goldfinger, S.E., Howell, R.R., Seegmiller, J.E.: Suppression of metabolic accompaniments of phagocytosis by colchicine. Arthr. and Rheum. 8, 1112–1122 (1965)
Goldstein, I., Hoffstein, S., Gallin, J., Weissmann, G.: Mechanisms of lysosomal enzyme release from human leukocytes: Microtubule assembly and membrane fusion induced by a component of complement. Proc. nat. Acad. Sci. (Wash.) 70, 2916–2920 (1973)
Goldstein, I., Hoffstein, S.T., Weissmann, G.: Influence of divalent cations upon complement-mediated enzyme release from human polymorphonuclear leukocytes. J. Immunol. 115, 665–670 (1975)
Greenbaum, L.M., Kin, K.S.: The kinin forming and kinidase activities of rabbit polymorphonuclear leukocytes. Brit. J. pharm. Chemother. 29, 238–247 (1967)
Hasselbacher, P., Schumacher, H. R. Jr.: Localization of immunoglobulin in gouty tophi by im-munohistology, and on the surface of monosodium urate crystals (MSU) by immune agglutination. Arthr. and Rheum. 19, 802 Abstr. (1976)
Henson, P.M.: Secretion of lysosomal enzymes induced by immune complexes and complement. In: Dingle, J.T., Dean, R.T. (Eds.): Lysosomes in Biology and Pathology, Vol. 5. New York: American Elsevier Publishers 1976
Hoffstein, S., Weissmann, G.: Mechanisms of lysosomal enzyme release from leukocytes. IV. Interaction of monosodium urate crystals with dogfish and human leukocytes. Arthr. and Rheum. 18, 153–165 (1975)
Horton, E.W.: Hypothesis on physiological roles of prostaglandins. Physiol. Rev. 49, 122–161 (1969)
Ignarro, L.J.: Regulation of lysosomal enzyme release by prostaglandins, autonomic neurohormones and cyclic nucleotides. In: Dingle, J.T., Dean, R.T. (Eds.): Lysosomes in Biology and Pathology, Vol. 4. New York: American Elsevier Publishers 1975
Janoff, A., Feinstein, G., Melemud, C., Elias, J.M.: Degradation of cartilage proteoglycan by human leukocyte granule neutral protease.—A model of joint injury. Penetration of enzyme into rabbit articular cartilage and release of 35SO4-labeled material from the tissue. J. clin. Invest. 57, 615–624 (1976)
Kaley, G., Weiner, R.: Prostaglandin E1: A potential mediator of the inflammatory response. Ann. N.Y. Acad. Sci. 180, 338–350 (1971)
Kellermeyer, R.W.: Hageman factor and acute gouty arthritis. Arthr. and Rheum. 11, 452–459 (1968)
Klinenberg, J.R., Bluestone, R., Schlosstein, L., Waisman, J., Whitehouse, M.W.: Urate deposition disease. How it is regulated and how can it be modified? Ann. intern. Med. 78, 99–111 (1973)
Kozin, F., McCarty, D.J.: Protein adsorption to monosodium urate, calcium pyrophosphate dihydrate, and silica crystals. Arthr. and Rheum. 19, 433–438 (1976a)
Kozin, F., McCarty, D.J.: Adsorption of protein monosodium urate crystals: A possible mechanism of crystal-induced inflammation. Arthr. and Rheum. (Abstr.) 19, 805 (1976 b)
Kozin, F., Skosey, J.L., May, J., Chow, D.C.: Modification of responses of human neutrophils to monosodium urate crystals by coating of crystals with serum proteins. Clin. Res. (Abstr.) 24, 331a (1976)
Lohmander, S., Moskalewski, S., Madsen, K., Thyberg, J., Friberg, V.: Influence of colchicine on the synthesis and secretion of proteoglycans and collagen by fetal guinea-pig chondrocytes. Exp. Cell Res. 99, 333–345 (1976)
McCall, E., Youlten, L.J.: Proceedings: Prostaglandin E1 synthesis by phagocytosing rabbit polymorphonuclear leukocytes: its inhibition by indomethacin and its role in Chemotaxis. J. Physiol. (Lond.) 234, 98–100 (1973)
McCarty, D.J., Jr.: On the crystal deposition diseases. Dis. Month. March (1970)
Malawista, S.E.: Colchicine: The common mechanism for its anti-inflammatory and anti-mytotic effects. Arthr. and Rheum. 11, 191–197 (1968)
Malawista, S.E., Bodel, P.T.: The dissociation by colchicine of phagocytosis from increased oxygen consumption in human leukocytes. J. clin. Invest. 46, 786–796 (1967)
Mandell, B., Spilberg, I.: Role of a chemotactic factor activated serine esterase in polymorphonuclear leukocytes capping. Clin. Res. 25, (Abstr.) 363 A (1977)
Mandell, B., Spilberg, I., Lichman, J.: Inhibitions of polymorphonuclear leukocyte capping by a chemotactic factor. J. Immunol. 118, 1375–1378 (1977)
Melmon, K.L., Webster, M.E., Goldfinger, S.E. et al.: The presence of a kinin in inflammatory synovial effusion from arthritides of varying etiologies. Arthr. and Rheum. 10, 13–20 (1967)
Movat, H.Z., Habal, F.M., Macmorine, D.R.L.: Generation of a vasoactive peptide by a neutral protease of human neutrophil leukocytes. Agents Actions 6, 183–190 (1976)
Musson, R., Becker, E.L.: The inhibitory effect of chemotactic factors on erythrophagocytosis by human neutrophils. J. Immunol. 117, 433–439 (1976)
Naff, G.B., Myers, P.H.: Complement as a mediator of inflammation in acute gouty arthritis. I. Studies on the reaction between human serum complement and sodium urate crystals. J. Lab. clin. Med. 81, 747–760 (1960)
Oliver, J.M., Zurier, R.B., Berlin, R.D.: Concanavalin-A cap formation on polymorphonuclear leukocytes of normal and beige (Chediak-Higashi) mice. Nature (Lond.) 253, 471–473 (1974)
Pekin, T.J., Zvaifler, N. J.: Hemolytic complement in synovial fluid. J. clin. Invest. 43, 1372–1382 (1964)
Phelps, P.: Polymorphonuclear leukocyte motility in vitro. IV. Colchicine inhibition of chemo-tactic activity formation after phagocytosis of urate-crystals. Arthr. and Rheum. 13, 1–12 (1970a)
Phelps, P.: Appearance of chemotactic activity following intraarticular injection of monosodium urate crystals: effect of colchicine. J. Lab. clin. Med. 76, 622–631 (1970b)
Phelps, P., McCarty, D.J., Jr.: Crystal induced inflammation in canine joints. II. Importance of polymorphonuclear leukocytes. J. exp. Med. 124, 115–127 (1966)
Phelps, P., McCarty, D.J.: Crystal induced arthritis. Postgrad, med. 45, 87–94 (1969)
Phelps, P., Prockop, D.J., McCarty, D.J.: Crystal induced inflammation in canine joints. III. Evidence against bradykinin as mediator of inflammation. J. Lab. clin. Med. 68, 433–444 (1966a)
Ratnoff, O.D.: The biology and pathology of the initial stages of blood coagulation. Progr. Hematol. 5, 204–245 (1966)
Rivkin, I., Rosenblat, J., Becker, E.L.: The role of cyclic AMP in the chemotactic responsiveness and expontaneous motility of rabbit peritoneal neutrophils. J. Immunol. 115, 1126–1134 (1975)
Ruddy, S., Gigli, I., Austen, F.: The complement system in man. I. New Engl. J. Med. 287, 489 – 495 (1972)
Rydgren, L., Simingskold, G., Bandman, V., Norberg, G.: The role of cytoplasmic microtubules in polymorphonuclear leukocyte Chemotaxis. Exp. Cell Res. 99, 207–220 (1976)
Rynes, R.I., Ruddy, S., Schur, P.H., Spragg, J., Austen, K.F.: Levels of complement components, properdin factors, and kininogen in patients with inflammatory arthritis. J. Rheum. 1, 413 – 427 (1974)
Sbarra, A.J., Karnovsky, M.L.: The biochemical basis of phagocytosis. J. biol. Chem. 234, 1355 – 1362(1959)
Schliwa, M.: The role of divalent cations in the regulation of microtubule assembly. J. Cell Biol. 70, 527–540 (1976)
Schotthauer, C.V., Bollman, J.I.: Spontaneous gout in turkeys. J. Amer. Vet. med. Ass. 85, 98 – 103 (1934)
Schlumberger, H.G.: Synovial gout in the parakeet. Lab. Invest. 8, 1304–1318 (1959)
Schumacher, H.R., Phelps, P.: Sequential changes in human polymorphonuclear leukocytes after urate crystal phagocytosis. An electron microscopy study. Arthr. and Rheum. 11, 145–150 (1968)
Scott, R.E.: Effects of prostaglandins, epinephrine and NaF on human leukocyte, platelet and liver adrenyl cyclase. Blood 35, 514–516 (1970)
Skosey, J.L., Kozin, F., Chow, D.C., May, J.: Differential responses of human neutrophils to monosodium urate crystals (MSU) and MSU coated with gamma globulin. Clin. Res. 24, (Abstr.) 11a (1976)
Smith, J.B., Willis, A.L.: Aspirin selectively inhibits prostaglandin production in human platelets. Nature (Lond.) New Biol. 231, 235–237 (1971)
Spilberg, I.: Studies on the mechanisms of inflammation induced by calcium pyrophosphate crystals. J. Lab. clin. Med. 82, 86–91 (1973)
Spilberg, J.: Urate crystal arthritis in animals lacking Hageman factor. Arthr. and Rheum. 17, 143–148 (1974)
Spilberg, I.: Current concepts of the mechanisms of acute inflammation in gouty arthritis. Arthr. and Rheum. 18, 129–134 (1975)
Spilberg, I., Gallacher, A., Mandell, B.: Studies on crystal induced chemotactic factor. II. Role of phagocytosis. J. Lab. clin. Med. 85, 631–636 (1975)
Spilberg, J., Gallacher, A., Mandell, B.: Calcium pyrophosphate dihydrate (CPPD) crystal induced chemotactic factor. Subcellular localization, role of protein synthesis and phagocytosis. J. Lab. clin. Med. 89, 817–822 (1977b)
Spilberg, I., Gallacher, A., Mehta, J.M., Mandell, B.: Urate crystal induced chemotactic factor. Isolation and partial characterization. J. clin. Invest. 58, 815–819 (1976)
Spilberg, I., Mandell, B., Wochner, R.D.: Studies on crystal induced chemotactic factor. I. Role of protein synthesis and neutral protease activity. J. Lab. clin. Med. 83, 56–63 (1974)
Spilberg, I., Osterland, C.K.: Anti-inflammatory effect of the trypsin-kallikrein inhibitor in acute arthritis induced by urate crystals in rabbits. J. Lab. clin. Med. 76, 472–479 (1970)
Spilberg, I., Rosenberg, D., Mandell, B.: Induction of arthritis by purified cell derived chemotactic factor. Role of Chemotaxis and vascular permeability. J. clin. Invest. 59, 582–585 (1977 c)
Spilberg, I., Rosenberg, D., Mehta, J.: Induction of cell derived chemotactic factor and of arthritis by amorphous diamond crystals. Arthr. and Rheum. (Abstr.) 20, 136 (1977d)
Spilberg, I., Tanphaichitr, K., Kantor, O.: Synovial fluid pH in acute gouty arthritis. Arthr. and Rheum. 20, 142 (1977 a)
Tse, R.L., Phelps, P., Urban, D.: Polymorphonuclear leukocyte motility in vitro. VI. Effect of purine and pyrimidine analogs: possible role of cyclic AMP. J. Lab. clin. Med. 80, 264–274 (1972)
Turner, R.A., Schumacher, H.R., Myers, A.R.: Phagocytic function of polymorphonuclear leukocytes in rheumatic diseases. J. clin. Invest. 52, 1632–1635 (1973)
Vane, J.R.: Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature (Lond.) New Biol. 231, 232–235 (1971)
Wallingford, W.R., McCarty, D.J.: Differential membranolytic effects of microcrystalline sodium urate and calcium pyrophosphate dihydrate. J. exp. Med. 133, 100–112 (1971)
Ward, P.A.: Complement derived chemotactic factors and their interaction with neutrophilic granulocytes. Ingrahm proceedings of the international symposium on the biological activities of complement, pp. 108–116. Basel: Karger AG 1971
Ward, P.A., Becker, E.L.: The deactivation of rabbit neutrophils by chemotactic factor and the nature of the activatable esterase. J. exp. Med. 127, 693–709 (1968)
Ward, P.A., Becker, E.L.: Biochemical demonstration of the activatable esterase of the rabbit neutrophil involved in the chemotactic response. J. Immunol. 105, 1057–1067 (1970)
Weissmann, G.: Lysosomal mechanisms of tissue injury in arthritis. New Engl. J. Med. 286, 141 – 147 (1972)
Weissmann, G., Rita, G.A.: Molecular basis of gouty inflammation: Interaction of monosodium urate crystals with lysosomes and lyposomes. Nature (Lond.) New Biol. 240, 167–172 (1972)
Weissmann, G., Spilberg, I., Krakauer, K.: Arthritis induced in rabbits by lysates of granulocyte lysosomes. Arthr. and Rheum. 12, 103–116 (1969)
Wilson, L., Banburg, J.R., Mizel, S.B. et al.: Interaction of drugs with microtubule proteins. Fed. Proc. 33, 158–166 (1974)
Zigmond, S.H.: Mechanisms of sensing chemical gradients by polymorphonuclear leukocytes. Nature (Lond.) 249, 450–452 (1974)
Zigmond, S.H., Hirsch, J.G.: Leukocyte locomotion and Chemotaxis. New methods for evaluation, and demonstration of a cell-derived factor. J. exp. Med. 137, 387–410 (1973)
Zurier, R.B., Quagliata, F.: Effect of prostaglandin E1 on adjuvant arthritis. Nature (Lond.) 234, 304–305 (1971)
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1978 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Spilberg, I. (1978). Role of the Leukocyte and Chemical Mediators of the Acute Gouty Attack. In: Kelley, W.N., Weiner, I.M. (eds) Uric Acid. Handbook of Experimental Pharmacology, vol 51. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-66867-8_15
Download citation
DOI: https://doi.org/10.1007/978-3-642-66867-8_15
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-66869-2
Online ISBN: 978-3-642-66867-8
eBook Packages: Springer Book Archive